{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:35Z","timestamp":1740147335535,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T00:00:00Z","timestamp":1711238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T00:00:00Z","timestamp":1711238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Botulinum toxin, produced by the Gram-positive anaerobe <jats:italic>Clostridium botulinum<\/jats:italic>, is composed of seven antigenic subtypes (A, B, C, D, E, F, and G). Currently, only Botulinum toxin type A, commonly referred to as \u201cBotox,\u201d is approved for clinical use, given its relatively safe clinical profile. Botulinum toxin type A has a wide range of therapeutic indications, including treatment for dystonia, migraine headache, neurogenic bladder, and large muscle spastic disorders. However, the toxin is most widely known for its cosmetic effects in treating wrinkles and facial lines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>This article describes a 62-year-old Caucasian female who presented for investigation and workup of an isolated lytic lesion of her frontal bone a few weeks after administration of botulinum toxin injection into the corresponding site in the frontalis muscle. This presented as a large, palpable, painless forehead lump causing significant psychological distress. After no neoplastic cause for the lesion was found and histopathology was performed, our researchers concluded that the most likely explanation was that the bony lytic lesion resulted from inadvertent injection of the \u201cBotox\u201d neurotoxin through the intended target muscle and into the cortex of the underlying bone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our search of the literature failed to identify any previous cases of this occurring. However, as the popularity of this cosmetic procedure only increases, we believe that this represents an important possible differential for isolated lytic lesion after administration of \u201cBotox\u201d injection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-024-04430-5","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T01:02:01Z","timestamp":1711242121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Botulinum toxin: a new differential diagnosis for a lytic bone lesion"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-5159","authenticated-orcid":false,"given":"Yael","family":"Lefkovits","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,24]]},"reference":[{"issue":"2","key":"4430_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1067\/mjd.2000.105567","volume":"43","author":"W Huang","year":"2000","unstructured":"Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43(2):249\u201359.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"4430_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2165\/00128071-200304100-00005","volume":"4","author":"JE Frampton","year":"2003","unstructured":"Frampton JE, Easthope SE. Botulinum Toxin A (Botox\u00ae cosmetic). Am J Clin Dermatol. 2003;4(10):709\u201325.","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"4430_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.toxicon.2009.01.015","volume":"54","author":"MF Brin","year":"2009","unstructured":"Brin MF. Development of future indications for BOTOX\u00ae. Toxicon. 2009;54(5):668\u201374.","journal-title":"Toxicon"},{"issue":"2","key":"4430_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/0974-2077.44169","volume":"1","author":"H Omprakash","year":"2008","unstructured":"Omprakash H, Rajendran S. Botulinum toxin deaths: what is the fact? J Cutan Aesthet Surg. 2008;1(2):95.","journal-title":"J Cutan Aesthet Surg"},{"key":"4430_CR5","unstructured":"Council AHMA. Cosmetic medical and surgical procedures. A national report. 2011."},{"issue":"3","key":"4430_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","volume":"53","author":"TR Cot\u00e9","year":"2005","unstructured":"Cot\u00e9 TR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005;53(3):407\u201315.","journal-title":"J Am Acad Dermatol"},{"key":"4430_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/CCID.S202919","volume":"12","author":"BK Satriyasa","year":"2019","unstructured":"Satriyasa BK. Botulinum toxin (Botox) A for reducing the appearance of facial wrinkles: a literature review of clinical use and pharmacological aspect. Clin Cosmet Investig Dermatol. 2019;12:223.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"4430_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s40902-018-0146-4","author":"H Seok","year":"2018","unstructured":"Seok H, Kim SG, Kim MK, Jang I, Ahn J. Effect of the massetr muscle injection of botulinum toxin A on the mandibular bone growth of developmental rats. Maxillofac Plast Reconstr Surg. 2018. https:\/\/doi.org\/10.1186\/s40902-018-0146-4.","journal-title":"Maxillofac Plast Reconstr Surg"},{"issue":"5","key":"4430_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s13244-018-0653-y","volume":"9","author":"L Ugga","year":"2018","unstructured":"Ugga L, Cuocolo R, Cocozza S, Ponsiglione A, Stanzione A, Chianca V, et al. Spectrum of lytic lesions of the skull: a pictorial essay. Insights Imaging. 2018;9(5):845\u201356.","journal-title":"Insights Imaging"},{"issue":"3","key":"4430_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1148\/radiol.2393050823","volume":"239","author":"AG Osborn","year":"2006","unstructured":"Osborn AG, Preece MT. Intracranial cysts: radiologic-pathologic correlation and imaging approach. Radiology. 2006;239(3):650\u201364.","journal-title":"Radiology"},{"issue":"4","key":"4430_CR11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2214\/AJR.14.13415","volume":"205","author":"L Colas","year":"2015","unstructured":"Colas L, Caron S, Cotten A. Skull vault lesions: a review. Am J Roentgenol. 2015;205(4):840\u20137.","journal-title":"Am J Roentgenol"},{"issue":"10","key":"4430_CR12","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2278::AID-CNCR25>3.0.CO;2-U","volume":"85","author":"DM Howarth","year":"1999","unstructured":"Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer. 1999;85(10):2278\u201390.","journal-title":"Cancer"},{"issue":"10","key":"4430_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ccr3.4993","volume":"9","author":"P Fadavi","year":"2021","unstructured":"Fadavi P, Arefpour AM, Hariri R, Vasheghani M, Garousi M, Taghizadeh-Hesary F. Dramatic response of aneurysmal bone cyst to denosumab: case report and literature review. Clin Case Rep. 2021;9(10):10.","journal-title":"Clin Case Rep."},{"key":"4430_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clinimag.2020.01.022","volume":"62","author":"LB Gutierrez","year":"2020","unstructured":"Gutierrez LB, Link TM, Horvai AE, Joseph GB, O\u2019Donnell RJ, Motamedi D. Secondary aneurysmal bone cysts and associated primary lesions: imaging features of 49 cases. Clin Imaging. 2020;62:23\u201332.","journal-title":"Clin Imaging"},{"issue":"1","key":"4430_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.fsc.2006.10.004","volume":"15","author":"J Carruthers","year":"2007","unstructured":"Carruthers J, Carruthers A. Complications of botulinum toxin type A. Facial Plast Surg Clin. 2007;15(1):51\u20134.","journal-title":"Facial Plast Surg Clin"},{"key":"4430_CR16","unstructured":"TB Fitzpatrick BG, LA Goldsmith, SL Katz, DJ Leffell. Fitzpatrick\u2019s dermatology in general medicine. 2012."},{"issue":"1","key":"4430_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1473-2165.2011.00593.x","volume":"11","author":"TC Flynn","year":"2012","unstructured":"Flynn TC. Advances in the use of botulinum neurotoxins in facial esthetics. J Cosmet Dermatol. 2012;11(1):42\u201350.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"4430_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/ejo\/cjq029","volume":"33","author":"C-Y Tsai","year":"2010","unstructured":"Tsai C-Y, Shyr Y-M, Chiu W-C, Lee C-M. Bone changes in the mandible following botulinum neurotoxin injections. Eur J Orthod. 2010;33(2):132\u20138.","journal-title":"Eur J Orthod"},{"issue":"2","key":"4430_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bone.2005.08.009","volume":"38","author":"SE Warner","year":"2006","unstructured":"Warner SE, Sanford DA, Becker BA, Bain SD, Srinivasan S, Gross TS. Botox induced muscle paralysis rapidly degrades bone. Bone. 2006;38(2):257\u201364.","journal-title":"Bone"},{"issue":"1","key":"4430_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1196\/annals.1402.009","volume":"1116","author":"SK Grimston","year":"2007","unstructured":"Grimston SK, Silva MJ, Civitelli R. Bone loss after temporarily induced muscle paralysis by Botox is not fully recovered after 12 weeks. Ann NY Acad Sci. 2007;1116(1):444\u201360.","journal-title":"Ann NY Acad Sci"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04430-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04430-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04430-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T01:02:17Z","timestamp":1711242137000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04430-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,24]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4430"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04430-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2024,3,24]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}